GENE ONLINE|News &
Opinion
Blog

Cardiovascular Disease
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Geneticists Find Loss of Y Chromosome in Aging Males Increases Risk of Heart Failure
2022-07-20
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Verve Cleared to Test Gene Editing Drug for Heart Disease in Humans
2022-05-12
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
True to Analyst Predictions, Amarin’s Shares Crash Following Vascepa Patent Invalidation
2020-03-31
Peptide Therapeutics Market: Promise for a Painless Future
2020-03-18
Will Vascepa Receive a FDA Approval as a New Year Gift?
2019-12-02
2019 Asia-Pacific Extracellular Vesicles Conference Made the World-leading Experts Gathered in Taipei
2019-01-19
LATEST
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Ways to Reduce Carbon Emission in Cement Manufacturing
2023-03-26
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
Scroll to Top